RADAR-AD: Alzheimer’s Disease
The RADAR programme aims to test if new pre-emptive therapeutic development and clinical care strategies based on remote continuous monitoring are both scientifically feasible and also practically feasible as part of a wider healthcare system.
Early stages of Alzheimer’s Disease (AD) are associated with cognitive decline, overlapping with increasing functional decline (impairments in the ability to perform daily activities of living), leading to progressive loss of independence and escalation of caregiver burden and medical costs.
The RADAR-Base platform will provide a critical resource for the collection, curation, and management, of complex real-time high-frequency streamed data for the RADAR-AD project.
Number of Participants: 200